Medical Wearable PCB: Why Smartwatch Precision Keeps Rising

The US FDA cleared Apple’s Hypertension Notification Feature through the 510(k) pathway for Apple Watch Series 9 and later and Apple Watch Ultra 2 and later. The feature does not measure blood pressure directly. It uses data collected by the optical heart rate sensor to analyze how the user’s blood vessels respond to each heartbeat, and identifies sustained hypertension-related patterns across a 30 day assessment period. Apple subsequently extended the feature to more than 150 countries and regions through watchOS 26.

For electronics manufacturing, the instructive part is not the feature itself but what it implies about the hardware underneath it.

Medical Features Raise the Signal Quality Requirement

Apple Watch already covers heart rate, electrocardiogram, atrial fibrillation history and sleep apnea. What distinguishes the hypertension feature is that it reuses the optical heart rate sensor while requiring the algorithm to identify subtler vascular response changes within long term photoplethysmography data. Apple has disclosed that algorithm training involved data from more than 100,000 participants, with validation through clinical studies involving over 2,000 people.

A medical feature upgrade therefore does not necessarily appear as an additional sensor. Frequently, what actually increases is the allowed noise level and required data stability of the existing sensing chain.

Photoplethysmography sensors produce weak analog signals. The light emitting diode, photodiode, analog front end, power management and digital processing circuitry are all concentrated within a very small watch body. Power supply ripple, crosstalk, grounding design and even solder joint consistency can influence the quality of the data that eventually reaches the algorithm.

The PCB’s role here is not connection. It is part of the signal acquisition chain itself. A grounding scheme that produces a few millivolts of noise on a digital board is inconsequential, but the same noise superimposed on a photoplethysmography front end appears as a physiological signal that the algorithm must then interpret.

Smaller Watch, More Function, More Interconnect Pressure

The contradiction in wearable design has always been clear. Functionality keeps increasing while internal volume does not.

The main controller, memory, wireless communication, health sensing, power management and display interface must be concentrated within a space measured in tens of millimeters, and the battery has to occupy as much volume as can be spared. The PCB therefore needs to increase routing and interconnect efficiency per unit area. Micro HDI, laser microvias and finer line structures shorten the distance between components and leave more layout room for the sensor and power regions.

Flexible circuits solve a different class of problem. Inside a watch, the display, sensors, battery, antenna and side button occupy physically different orientations. A rigid board cannot easily connect them within such a compact structure. Flexible circuits can be routed along the enclosure, reducing connector count and occupied volume while helping to control overall weight.

In medical monitoring applications, those advantages have to be built on a foundation of stability. Traces can be finer, but line width and spacing, coverlay alignment and the bend region cannot exhibit larger batch-to-batch variation as a result. A dimensional variation that changes the impedance of a sensor link changes the shape of the signal that the algorithm receives.

This is where PCB fabrication capability has to be assessed against measured consistency rather than against minimum feature size. A supplier able to produce fine lines on a sample and a supplier able to hold those dimensions across production lots are describing different capabilities, and only the second one supports a regulated medical feature.

From Fitting Inside to Measuring Accurately

Consumer electronics PCB development has long pursued miniaturization and integration. Medical and health functionality adds a layer of long term reliability constraint on top.

The hypertension feature analyzes continuous data across 30 days. A small error in a single sample may be invisible, but across long term data collection, drift in the sensor interface, power supply or solder joints can affect data continuity. A joint whose resistance shifts slightly with temperature produces a slow baseline movement that is indistinguishable from a physiological change at the algorithm level.

High density SMT therefore has to address more than shrinking component sizes. Solder paste volume, placement offset, void content and the stability of hidden BGA joints all become relevant. A void beneath a sensor interface component that passes electrical test at room temperature can alter thermal behavior enough to shift the analog reading once the watch warms against the wrist.

This is why PCBA testing signals such as solder paste inspection, automated optical inspection and X-ray gain significance in this product category. They are not there to add inspection steps for their own sake. They exist to surface placement, soldering and hidden joint anomalies before the product reaches a wearer, because at that point the anomaly is a measurement error rather than a manufacturing defect.

Coordination between board fabrication and assembly matters for the same reason. When medical PCBA assembly and flex PCB assembly are handled under a shared process discipline with the board itself, a drift detected at functional test can be traced to a specific fabrication or assembly parameter. When those stages are split across suppliers, the same drift tends to be attributed to sensor variability, which cannot then be investigated.

Where the Additional Value Comes From

A software feature going live does not multiply the price of a PCB. What matters is the product trajectory behind it: consumer wearables are carrying an increasing number of health functions that require regulatory clearance and clinical validation.

As devices take on more significant health determinations, the increment available to the PCB industry is not limited to shipment volume. Micro HDI, flexible circuits, high density sensor modules and precision assembly all become more important within the product, and manufacturing evaluation criteria extend from size and cost toward signal stability, batch consistency and long term reliability.

That extension has a measurable form. Signal stability means the noise floor of the acquisition chain is characterized and controlled. Batch consistency means the distribution of line width, impedance and joint quality is known across lots. Long term reliability means the behavior has been verified under temperature and humidity cycling rather than only at room temperature.

Demonstrating those attributes requires a quality management system that retains records at the lot level and can connect a finished device back to the material and process conditions that produced it. For regulated health features, that traceability is a regulatory expectation rather than an engineering preference, and it propagates from the finished device back through the assembly line to the board fabricator.

Validating Long Term Drift Rather Than Instant Accuracy

Medical wearable validation differs from consumer electronics validation in what it measures and over what period.

A consumer device is typically judged on functional accuracy at the point of manufacture. A health monitoring feature has to remain accurate over weeks of continuous operation, through temperature changes as the device warms and cools against the skin, through battery discharge, and through the mechanical movement of daily wear.

That changes the test strategy. Instead of a single functional check, the relevant validation runs the assembled device through its operating envelope while logging the sensor output against a reference. A gradual shift in the baseline under temperature cycling points to a hardware cause, whether in the analog front end, the grounding scheme or a solder joint, and it can be addressed during development rather than discovered from clinical data.

Where a program includes flexible interconnect crossing a moving area, the same principle applies mechanically. Repeated flexing that changes resistance slightly with each cycle produces a slow drift rather than an immediate failure, and only a test that tracks the baseline over many cycles will detect it. Designing that measurement into the validation plan is more efficient than attempting to identify the cause later from field data.

Coverlay, Stiffener and Coating on a Curved Product

Watch internals are not flat, and the flexible circuits that connect modules are shaped to follow the enclosure. That geometry interacts with every material decision.

Coverlay openings and stiffener placement determine where the flex can bend and where it must remain rigid. A stiffener positioned to protect a solder joint also creates a boundary at which bending stress concentrates, so its dimensions affect mechanical life. Coating applied for moisture protection adds stiffness as well, which is beneficial in a rigid region and potentially harmful in a flexing one.

These are mechanical decisions with electrical consequences. Reducing coverlay thickness to improve flexibility changes the distance between the trace and the reference plane, which changes characteristic impedance on high speed links. Increasing stiffener thickness to protect a component changes the local stackup in the same way.

Resolving those conflicts requires evaluating the flex as a system rather than applying standard thicknesses for each layer. For medical wearables, where the sensing chain is sensitive to impedance variation, this analysis belongs in the design review rather than in a post-build correction.

What to Watch Next

The more interesting question for the industry is not how many additional health features a smartwatch can support. It is whether consumer electronics manufacturing systems, built around miniaturization and cost efficiency, can simultaneously achieve the data stability and quality traceability that medical products require.

Those two objectives have different optimization targets. Miniaturization rewards smaller features and tighter packing. Medical reliability rewards margin, verification and documented consistency. Products that must satisfy both push manufacturing toward precision processes with rigorous measurement rather than toward either extreme.

For engineering teams developing health monitoring wearables, the practical implication is to define the electrical and reliability requirements of the sensing chain explicitly, rather than treating them as consequences of component selection. Grounding strategy, analog and digital partitioning, material choice, coating coverage and joint quality all influence what the algorithm receives, and all of them are decided during board and assembly design.

Engaging the manufacturing partner while those decisions are still open is what makes the requirements achievable. Once a design is frozen, the available responses narrow to screening and rework, neither of which addresses a systematic issue in the acquisition chain. The watch is small, but the engineering work behind the numbers it reports is not.